Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Avipox recombinants expressing foot and mouth disease virus genes

Avipox recombinants expressing foot and mouth disease virus genes

US Patent 7527960 · Granted May 5, 2009

Estimated economic value: $95,355,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reassortant BTV and AHSV vaccines2020
Methods for freeze-drying and rehydrating biologics2020
Antibiotic-free plasmid2019
FMDV and E2 fusion proteins and uses thereof2019
Hendra virus recombinant compositions and uses thereof2019
High resolution melt genotyping of IBV, CSFV and NDV2018
Recombinant CDV compositions and uses thereof2018
FMDV recombinant vaccines and uses thereof2018
FMDV and E2 fusion proteins and uses thereof2018
Needle-free administration of PRRSV vaccines2017
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and u2017
Bluetongue virus recombinant vaccines and uses thereof2016